Drug intelligence / Profile preview

Actazin + PreticX

Development stage
Unknown
Lead developer
AIDP
Modality
Microbiome Therapeutics
Administration
Oral
01

Overview

Actazin + PreticX is a patented dietary supplement combination developed by AIDP, Inc., designed to support digestive health and gut microbiota modulation. The formulation combines Actazin, a cold-pressed green or gold kiwifruit extract from New Zealand that is rich in the proteolytic enzyme actinidin, with PreticX, a xylooligosaccharide (XOS) prebiotic. The combination works synergistically to improve bowel regularity and alleviate functional constipation by selectively promoting the growth of beneficial gut bacteria, such as Bifidobacteria, and aiding in protein digestion. Clinical trials have demonstrated its efficacy in increasing complete spontaneous bowel movements in healthy adults, making it a non-pharmaceutical option for managing occasional gastrointestinal discomfort.

Brand names
ENDUR Prebiotic Plus
Other names
kiwifruit extract and xylooligosaccharide combinationActazin and PreticX combination

Beyond the preview

Go deeper on Actazin + PreticX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actazin + PreticX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call